Latin America Insulin Infusion Pump Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Latin America Continuous Subcutaneous Insulin Therapy Devices Market and it is segmented by Component (Pump Device, Infusion Set, and Reservoir) and Geography (Mexico, Brazil, and Rest of Latin America.

Latin America Insulin Infusion Pump Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Latin America Insulin Infusion Pump Market Size

View Global Report
Latin America Insulin Infusion Pump Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 123.05 Million
Market Size (2030) USD 157.80 Million
CAGR (2025 - 2030) 5.10 %

Major Players

Latin America Insulin Infusion Pump Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Latin America Insulin Infusion Pump Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Latin America Insulin Infusion Pump Market Analysis

The Latin America Insulin Infusion Pump Market size is estimated at USD 123.05 million in 2025, and is expected to reach USD 157.80 million by 2030, at a CAGR of 5.1% during the forecast period (2025-2030).

The pandemic that everyone was talking about before COVID-19, is a challenge to health systems and a threat to their financial viability. The improper use of corticosteroids and the presence of diabetes mellitus in patients during the Coronavirus Disease 2019 (COVID-19) pandemic marked the beginning of an increased incidence of fungal infections such as aspergillosis and mucormycosis in patients with this emerging viral infection. More than 200 cases have been reported in the literature in Latin America, ranging from Mexico to Argentina. Most cases have come from Brazil. Before COVID-19, the number of cases had been increasing while the mortality rate had been decreasing. Access to telemedicine is critical for managing chronic diseases in children, such as type 1 diabetes. Telemedicine was implemented in Latin American countries because of the COVID-19 pandemic, which had a positive impact on the health system. Telemedicine could result in financial savings by avoiding transportation expenses, class and parental working hours lost, time lost for transportation to distant referral health centers, and improving the quality of life, socioeconomic level, and environment."

An insulin pump (also known as continuous subcutaneous insulin therapy) is a medical device used to administer insulin to treat diabetes. Insulin pumps make it possible to deliver continuous infusion amounts of insulin at regular intervals. It is predicted to result in long-term cost savings relative to multiple daily injections. The traditional pump includes the pump (including controls, a processing module, and batteries), a disposable reservoir for insulin (inside the pump), and a disposable infusion set, including a cannula for subcutaneous insertion (under the skin) and a tubing system to connect the insulin reservoir to the cannula. The device configuration may vary depending on the design. However, the application of infusion pumps is increasing significantly across the Latin American region.

Latin America Insulin Infusion Pump Industry Overview

The new technologies in Insulin Infusion Pump devices increased the market for Insulin Pump devices. Animas had to exit the insulin pump market owing to the rising competition. Medtronic is the market leader and is expected to maintain its position during the forecast period.

Latin America Insulin Infusion Pump Market Leaders

  1. Roche

  2. Ypsomped

  3. Insulet

  4. Medtronic

  5. Tandem

  6. *Disclaimer: Major Players sorted in no particular order
Latin America Insulin Infusion Pump Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Latin America Insulin Infusion Pump Market News

  • February 2022: The US Food and Drug Administration (FDA) granted approval for Tandem Diabetes Care's t: slim X2 insulin pump to bolus using the t: connect mobile app. The updated mobile application is intended to allow users of the t: slim X2 insulin pump to easily program and cancel bolus insulin requests through their smartphone.
  • January 2022: FDA approved an automated tubeless insulin pump for people with type 1 diabetes. The Omnipod 5 is fully controlled via a smartphone app, eliminating the need to carry a separate device. It delivers insulin through a pod, smaller than the size of a desktop mouse, that the user manually fills with insulin, adheres to their skin, typically on their stomach, and replaces every three days.

Latin America Insulin Infusion Pump Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Drivers
  • 4.3 Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. Market Segmentation

  • 5.1 Device
    • 5.1.1 Insulin Pump Monitors
    • 5.1.2 Insulin Infusion Pump
    • 5.1.3 Reserviour
  • 5.2 Geography
    • 5.2.1 Mexico
    • 5.2.2 Brazil
    • 5.2.3 Rest of Latin America

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes Population
  • 6.2 Type-2 Diabetes Population

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Medtronic
    • 7.1.2 Insulet
    • 7.1.3 Roche
    • 7.1.4 Animas
    • 7.1.5 Tandem
    • 7.1.6 Ypsomed
    • 7.1.7 Cellnovo
    • 7.1.7.1 Other Key Players
  • *List Not Exhaustive
  • 7.2 Company Share Analysis

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
* We will provide a segment-wise breakdown (Value and Volume) for all the countries covered under the Table of Contents. **Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Latin America Insulin Infusion Pump Industry Segmentation

A tiny, computerized insulin pump can give insulin in two ways: either as a constant, measured, and continuous dosage (known as "basal" insulin) or as a surge ("bolus") dosage just before meals. The Latin America Insulin Infusion Pump Market is segmented by Component (Pump Device, Infusion Set, and Reservoir) and Geography (Mexico, Brazil, and Rest of Latin America. The report offers the value (in USD million) and Volume (in Unit million) for the above segments. We will provide a segment-wise breakdown (Value and Volume) for all the countries covered under the Table of Contents.

Device Insulin Pump Monitors
Insulin Infusion Pump
Reserviour
Geography Mexico
Brazil
Rest of Latin America
Need A Different Region or Segment?
Customize Now

Latin America Insulin Infusion Pump Market Research FAQs

How big is the Latin America Insulin Infusion Pump Market?

The Latin America Insulin Infusion Pump Market size is expected to reach USD 123.05 million in 2025 and grow at a CAGR of 5.10% to reach USD 157.80 million by 2030.

What is the current Latin America Insulin Infusion Pump Market size?

In 2025, the Latin America Insulin Infusion Pump Market size is expected to reach USD 123.05 million.

Who are the key players in Latin America Insulin Infusion Pump Market?

Roche, Ypsomped, Insulet, Medtronic and Tandem are the major companies operating in the Latin America Insulin Infusion Pump Market.

What years does this Latin America Insulin Infusion Pump Market cover, and what was the market size in 2024?

In 2024, the Latin America Insulin Infusion Pump Market size was estimated at USD 116.77 million. The report covers the Latin America Insulin Infusion Pump Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Latin America Insulin Infusion Pump Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Latin America Insulin Infusion Pump Industry Report

Statistics for the 2025 Latin America Insulin Infusion Pump market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Latin America Insulin Infusion Pump analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.